Image of Pf Awards 2020 logo to indicate pf awards 2020 coronavirus update

Pf Awards 2020 urgent announcement

It is with deepest regret that we have taken the decision to cancel the Pf Awards 2020. The escalating situation with the coronavirus has...
Image of a brain with a lightning bolt on it to show Around 10,000 people could benefit from new migraine drug

Around 10,000 people could benefit from new migraine drug

NICE has published final draft guidance which recommends fremanezumab (Ajovy, Teva Pharmaceuticals) for preventing chronic migraine meaning around 10,000 people could benefit from the...
Image of a scientist in the lab to indicate Medicines Discovery Catapult nurture next generation drug discovery researchers

Medicines Discovery Catapult nurture next generation drug discovery researchers

Medicines Discovery Catapult (MDC) has welcomed a cohort of MRC-funded PhD students as part of a training, talent and skills agenda to help develop...
Image of lab equipment to show Long-term phase III study data on HIV-1 treatment regimen published

Long-term phase III study data on HIV-1 treatment regimen published

ViiV Healthcare has presented 96-week data from its global phase III FLAIR study of the investigational, long-acting, injectable, 2-drug regimen of ViiV Healthcare’s cabotegravir...
Image of two men sat as a table with a two halves of a speech bubble that it coming together like a jigsaw piece to show ViiV Healthcare and UNC-Chapel Hill announce five-year renewal of innovative HIV cure partnership

ViiV Healthcare and UNC-Chapel Hill announce five-year renewal of innovative HIV cure partnership

ViiV Healthcare and UNC-Chapel Hill have announced a five-year renewal of their innovative HIV cure partnership. ViiV Healthcare, the global specialist HIV company majority owned...
Image of Pf Awards 2020 logo to indicate pf awards 2020 coronavirus update

Pf Awards 2020 coronavirus update 

It is with deepest regret that we have taken the decision to cancel the Pf Awards 2020. Please see our updated statement. With the Pf...
Image of a calendar and alarm clock to show New opioid dependency implant to prevent withdrawal symptoms

New opioid dependency implant to prevent withdrawal symptoms

A new opioid dependency implant to prevent withdrawal symptoms has been deemed more favourable than sublingual tablets, according to a new benefit-risk study published...
Imag eof a man flying upwards out of a light bulb to show Pharma appraisals, approvals and launches

Pharma appraisals, approvals and launches

Pf's weekly summary of pharma appraisals, approvals and launches, including NICE recommendation of avatrombopag and the FDA's approval of Sanofi's Sarclisa® in combination. UK The National...
Hub and spoke dispensing not necessarily safer or more cost effective

Commonly prescribed Alzheimer’s drugs affect activity of another

TauRx Therapeutics have published a study in an Alzheimer’s disease (AD) mouse model which demonstrates that drugs currently used to manage the symptoms of...
Image of a selection of medicines to show AstraZeneca completes hypertension medicine divestment

AstraZeneca completes hypertension medicine divestment

AstraZeneca has completed its previously communicated hypertension medicine divestment, following agreement with Atnahs Pharma to divest its global commercial rights to Inderal (propranolol), Tenormin (atenolol), Tenoretic (atenolol, chlorthalidone fixed-dose...

Latest articles

Image of a scientist at a lab to show Life sciences industry releases COVID-19 testing and diagnostics FAQs

Life sciences industry releases COVID-19 testing and diagnostics FAQs

The life sciences industry released a joint statement on COVID-19 testing and diagnostics along with useful COVID-19 testing and diagnostics FAQs. The FAQs have been...
Image of a scientist testing to show Life sciences COVID-19 testing and diagnostics statement

Life sciences’ COVID-19 testing and diagnostics statement

The life sciences industry has released a joint statement on COVID-19 testing and diagnostics as the Government confirms that testing capacity will increase. The statement...
Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...

Popular articles

Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Image of a form with ticks to show MHRA guidance on coronavirus (COVID-19)

UPDATED: MHRA guidance on coronavirus (COVID-19)

The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Image of lab equipment to show Synairgen to start trial of SNG001 in COVID-19

Synairgen to start trial of SNG001 in COVID-19

Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...
Image of a hospital corridor to show Interim analysis data for Siltuximab-Treated COVID-19 Patients from the SISCO Study

Interim analysis data for Siltuximab-Treated COVID-19 Patients study

An update on the Siltuximab clinical study brings interim analysis data for Siltuximab-Treated COVID-19. EUSA Pharma has announced the initial preliminary findings from the Papa...
Seqirus starts on-time delivery of NHS flu vaccines

Seqirus starts on-time delivery of NHS flu vaccines

Seqirus has started on-time shipping of its NHS flu vaccines portfolio, FLUAD® (aTIV) and FLUCELVAX® TETRA▼(QIVc), to healthcare professionals across the UK. Delivering Seqirus’ flu...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription